Van Kolfschoten A A, Olling M, Van Noordwijk J
Pharm Weekbl Sci. 1985 Feb 22;7(1):15-9. doi: 10.1007/BF01962864.
The influence of concurrent administration of paracetamol with indomethacin on the plasma concentrations of these drugs was studied in rats. Orally administered paracetamol reduced the plasma levels of indomethacin during the first 2 hours after oral administration. Later, 16 and 24 hours after administration of indomethacin, the plasma levels exceeded the control values due to the concurrent oral administration of paracetamol. These data suggest that paracetamol delayed the absorption of indomethacin. In contrast the plasma concentrations of paracetamol were not influenced substantially by indomethacin. When paracetamol was co-administered subcutaneously with oral indomethacin, the plasma levels of the latter drug were not influenced. It is concluded that the protective effect of paracetamol against the gastric injuring side effect of indomethacin, which also occurs with subcutaneous administration of paracetamol, cannot be solely due to lowered plasma concentrations of indomethacin.
在大鼠中研究了对乙酰氨基酚与吲哚美辛同时给药对这些药物血浆浓度的影响。口服对乙酰氨基酚在口服后最初2小时内降低了吲哚美辛的血浆水平。之后,在吲哚美辛给药16和24小时后,由于同时口服对乙酰氨基酚,血浆水平超过了对照值。这些数据表明对乙酰氨基酚延迟了吲哚美辛的吸收。相反,吲哚美辛对对乙酰氨基酚的血浆浓度没有实质性影响。当对乙酰氨基酚与口服吲哚美辛皮下联合给药时,后一种药物的血浆水平不受影响。得出的结论是,对乙酰氨基酚对吲哚美辛胃损伤副作用的保护作用(皮下注射对乙酰氨基酚时也会出现这种保护作用)不能仅仅归因于吲哚美辛血浆浓度的降低。